PFE

Pfizer Inc. (PFE)

Last Price$24.8(4.7%)
Market Cap$163.3B
LTM Revenue
$60.1B
YoY Growth
-12.3%
3Y CAGR
-4.6%
5Y CAGR
+2.5%
Stock quality & Intrinsic value
5/10
1.1% undervalued

Pfizer Inc. Revenue

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
$52.5B
$51.3B
$48.4B
$48.4B
$48.3B
$50.0B
$67.8B
$67.4B
$59.0B
$51.6B
$49.6B
$48.9B
$52.8B
$52.5B
$53.6B
$51.8B
$41.9B
$81.3B
$100.3B
$58.5B
See the PFE
full fundamental analysis
View -->
Overvalued or undervalued?
Check the intrinsic value for PFE
Explore -->

Pfizer Inc. (PFE) Revenue comparison analysis

Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Pfizer Inc.'s Revenue?

As of today, Pfizer Inc.'s last 12-month Revenue is $60.1B, based on the financial report for Sep 29, 2024 (Q3 2024).

2) What is Pfizer Inc.'s Revenue growth rate?

Over the last year, Pfizer Inc.'s Revenue growth was (12.3%). The average annual Revenue growth rates for Pfizer Inc. have been 6.2% over the past three years, 2.5% over the past five years.

3) Is Pfizer Inc.'s Revenue growth rate Good?

Over the last year, Pfizer Inc.'s Revenue growth was (12.3%), which is lower than industry growth of 0.1%. It indicates that Pfizer Inc.'s Revenue growth is Bad.

4) How does Pfizer Inc.'s Revenue growth rate compare to its peers?

Over the last year, Pfizer Inc.'s Revenue growth was (12.3%), which is lower than peer median growth of 7.2%. The list of peers includes JNJ, SNY, MRK, ABBV, AZN, NVS, BMY, LLY, AMGN, GILD etc.